Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11‐Mutated Juvenile Myelomonocytic Leukemia
Hisato Segoe, Jutaro Abe, Shinsuke Hirabayashi, Risa Nakashima, Kazumi Oura, Yukayo Terashita et al. Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11‐Mutated Juvenile Myelomonocytic Leukemia. // Pediatric Blood and Cancer. – 2026. – DOI: 10.1002/1545-5017.70758. – URL: https://onlinelibrary.wiley.com/doi/10.1002/1545-5017.70758?af=R
Hisato Segoe, Jutaro Abe, Shinsuke Hirabayashi, Risa Nakashima, Kazumi Oura, Yukayo Terashita, Yuko Cho, Daichi Sajiki, Hideki Muramatsu, & Atsushi Manabe (2026). Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11‐Mutated Juvenile Myelomonocytic Leukemia. Pediatric Blood and Cancer. https://doi.org/10.1002/1545-5017.70758
Hisato Segoe, et al. “Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11‐Mutated Juvenile Myelomonocytic Leukemia.” Pediatric Blood and Cancer, 2026. doi:10.1002/1545-5017.70758.
@article{Segoe2026,
title = {Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11‐Mutated Juvenile Myelomonocytic Leukemia},
author = {Segoe, Hisato and Abe, Jutaro and Hirabayashi, Shinsuke and Nakashima, Risa and Oura, Kazumi and Terashita, Yukayo and Cho, Yuko and Sajiki, Daichi and Muramatsu, Hideki and Manabe, Atsushi},
journal = {Pediatric Blood and Cancer},
year = {2026},
doi = {10.1002/1545-5017.70758},
url = {https://onlinelibrary.wiley.com/doi/10.1002/1545-5017.70758?af=R}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...